- Home
- UUUU vs SRRK Comparison
UUUU vs SRRK Comparison
Compare UUUU & SRRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UUUU
- SRRK
- Stock Information
- Founded
- UUUU 1987
- SRRK 2012
- Country
- UUUU United States
- SRRK United States
- Employees
- UUUU N/A
- SRRK N/A
- Industry
- UUUU Mining & Quarrying of Nonmetallic Minerals (No Fuels)
- SRRK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- UUUU Industrials
- SRRK Health Care
- Exchange
- UUUU Nasdaq
- SRRK Nasdaq
- Market Cap
- UUUU 3.6B
- SRRK 3.0B
- IPO Year
- UUUU N/A
- SRRK 2018
- Fundamental
- Price
- UUUU $20.51
- SRRK $29.62
- Analyst Decision
- UUUU Strong Buy
- SRRK Strong Buy
- Analyst Count
- UUUU 5
- SRRK 9
- Target Price
- UUUU $14.95
- SRRK $47.88
- AVG Volume (30 Days)
- UUUU 34.6M
- SRRK 3.2M
- Earning Date
- UUUU 11-03-2025
- SRRK 11-14-2025
- Dividend Yield
- UUUU N/A
- SRRK N/A
- EPS Growth
- UUUU N/A
- SRRK N/A
- EPS
- UUUU N/A
- SRRK N/A
- Revenue
- UUUU $65,078,999.00
- SRRK N/A
- Revenue This Year
- UUUU N/A
- SRRK N/A
- Revenue Next Year
- UUUU $105.42
- SRRK $1,911.27
- P/E Ratio
- UUUU N/A
- SRRK N/A
- Revenue Growth
- UUUU 42.73
- SRRK N/A
- 52 Week Low
- UUUU $3.20
- SRRK $22.71
- 52 Week High
- UUUU $27.33
- SRRK $46.98
- Technical
- Relative Strength Index (RSI)
- UUUU 53.05
- SRRK 41.89
- Support Level
- UUUU $19.15
- SRRK $28.82
- Resistance Level
- UUUU $23.41
- SRRK $30.15
- Average True Range (ATR)
- UUUU 2.97
- SRRK 1.52
- MACD
- UUUU -0.44
- SRRK -0.15
- Stochastic Oscillator
- UUUU 28.59
- SRRK 30.73
About UUUU Energy Fuels Inc (Canada)
Energy Fuels Inc is a United States-based critical minerals company. The Company mines uranium and produces natural uranium concentrates that are sold to nuclear utilities for the production of carbon-free nuclear energy. It holds two of America's key uranium production centers: The White Mesa Mill in Utah, and the Nichols Ranch ISR Facility in Wyoming. It has three reportable segments based on its operations and financial information; Uranium, HMS, and REE.
About SRRK Scholar Rock Holding Corporation
Scholar Rock Holding Corp is a late-stage biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for treating serious diseases in which signaling by protein growth factors plays a fundamental role. Its pipeline includes Neuromuscular and Obesity, Immuno-oncology, Fibrotic Disease, and Hematology. The group operates and manages its business as a single segment to assess performance and make operating decisions.